Revascularization in severe left ventricular dysfunction: The role of viability testing

Panithaya Chareonthaitawee, Bernard J. Gersh, Philip A. Araoz, Raymond J. Gibbons

Research output: Contribution to journalReview articlepeer-review

101 Scopus citations


Revascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.

Original languageEnglish (US)
Pages (from-to)567-574
Number of pages8
JournalJournal of the American College of Cardiology
Issue number4
StatePublished - Aug 16 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Revascularization in severe left ventricular dysfunction: The role of viability testing'. Together they form a unique fingerprint.

Cite this